Today’s AI Top Pick: TCOM
8/4/2026 · Forecast Pure screen · a free sample of K3vl4r’s AI-curated picks.
AI-ranked from a screened shortlist, with entry strategy, targets, and risks.
View the live TCOM price forecast →
TCOM is the only name in the pool with genuine multi-timeframe alignment AND a clean fundamental profile AND a non-toxic news backdrop. All four Kronos horizons print positive on the mid/long forecasts: 1h +2.6/+1.44/-2.74, 4h +3.7/+1.18/+13.01, 1d +10.35/+29.32/+24.67, and 1wk +1.42/+5.41/+9.4. That 1d mid-forecast of +29% with the weekly independently corroborating at +9.4% is exactly the kind of internal consistency the lens is built for — you don't see one blown-out single-bar outlier dragging the story. Bullish_prob=1.0 and near_term_bullish=0.8 back the picture. Entry timing is favorable rather than chased. The 1h position-in-range is only 17.06% (with a −2.05% pullback from the 21-bar high) and the weekly is at 39.23% with a −15.75% drawdown — so we are buying into a consolidation after a multi-month cool-off (perfYtd −34.22%, perfYear −22%), not extending a parabolic move. Compare that to APGE, BFH, or SAN which are pinned at 90–100% of range with weekly forecasts of −50% to −67% — classic short-side setups the model is flagging against. Fundamentals are the tiebreaker that pushes TCOM above the other bullish_prob=1 names (DKNG, PONY, NFGC, TEM). Fundamental_score of 8 (top of pool), PE 7.45, fwdPe 11.55, PEG-adjacent growth via epsNextY +17.13, salesYoY +19.28, ROE 20%, profit margin 48.4%, debt/equity 0.19, analyst recom 1.44 (Strong Buy) and 25.6% target upside. DKNG has a PE of 390 and D/E of 3.17; PONY has an operating margin of −239%; NFGC is unprofitable. Only TCOM offers cheap growth + strong forecast. On news: the July 31 antitrust fine headline reads worse than it is — Benzinga's own framing is that Trip.com was 'spared a major overhaul,' i.e., regulatory overhang is resolving at the low end. Citi maintained Buy the same week (PT $62). No dilution, no short-seller report, no guidance cut. Reason to buy TODAY: forecast strength peaks in the mid-window (1d fc_mid +29%), price sits near the bottom of its 1h range, and the regulatory landmine just cleared. Waiting risks entering after the gap.

- China ADR headline/regulatory risk — the July 31 fine was resolved mildly but Beijing anti-monopoly posture can re-escalate; a fresh probe would break the setup
- 1h position-in-range is 17% but 1d position is 87% — a shakeout back toward $44 is possible before the trend resumes
- Weekly recent_21bar_pct is −8.93% and dd_from_21bar_high is −15.75%; if it breaks the weekly low, the entire pattern invalidates
- USD/CNY volatility and Chinese travel-demand data (macro sensitivity above what fundamentals imply)
- Analyst PTs have been trimmed (Citi cut to $62 from higher), signaling that even bulls are moderating — cap position sizing accordingly
| # | Symbol | Verdict | Score | Read |
|---|---|---|---|---|
| 1 | TCOM | BUY NOW | 8.6 | Only name with all-TF bullish forecast, cheap valuation (PE 7.45, fwdPe 11.55, ROE 20%), and cleanly-resolved regulatory overhang. |
| 2 | TEM | BUY NOW | 7.4 | AI-healthcare thesis with 1d fc_mid +47% and price at 24% of range after 25% drawdown — high-variance but forecast-model favorite. |
| 3 | DKNG | BUY NOW | 7.1 | 1wk fc_long +43% and Burry long, but nosebleed PE 390 caps conviction. |
| 4 | PONY | BUY PULLBACK | 6.5 | Robotaxi story with 4h fc_long +57%/1d fc_mid +64%, but −239% operating margin means every entry is a coin flip. |
| 5 | 1INCH-USD | BUY NOW | 5.9 | Weekly fc_long +174% with all-TF alignment and positive DeFi liquidity-layer catalyst; crypto beta acknowledged. |
| 6 | SAFE-USD | BUY NOW | 5.6 | 1d bullish across horizons (+15/+12/+17) after −19% dd, near-term bullish 1.0. |
| 7 | BLAST-USD | BUY PULLBACK | 5.4 | 1d fc_long +108% but only one TF available — single-signal risk. |
| 8 | NFGC | BUY PULLBACK | 5.2 | Multi-TF gold-junior +34/+72% weekly, but profit margin −368% keeps size tiny. |
| 9 | FIDA-USD | BUY NOW | 5.1 | 1d fc_long +46% off the range low (0%) with near-term bullish 1.0. |
| 10 | CRML | BUY PULLBACK | 4.9 | 1d fc_mid +40%, but 4h shows −35% recent bar and analyst overvaluation flag — messy. |
| 11 | AXS-USD | BUY PULLBACK | 4.5 | 1d fc_long +64% off deep drawdown but weekly still bleeding (−24%). |
| 12 | TNSR-USD | BUY PULLBACK | 4.2 | 1d fc_long +50% but weekly forecast is −17 to −43%; wait for weekly stabilization. |
| 13 | GPRO | BUY PULLBACK | 4.0 | Big forecasts (+64% weekly fc_long) but sub-$1 stock with fundamental_score −3.75 — lottery ticket only. |
| 14 | PBR-A | WAIT | 3.5 | Cheap (PE 5.5) but Kronos flips bearish beyond 1h (1d fc_long −23%, 1wk −43%). |
| 15 | ALEC | WAIT | 3.3 | Positive forecasts undercut by GSK ending brain-drug alliance — pipeline reset is a landmine. |
| 16 | SEI | WAIT | 3.0 | Wells Fargo upgrade but Kronos weekly fc_long −76%; strong disagreement, sit out. |
| 17 | SIMO | AVOID | 2.6 | Fundamentals shine (fwdPe 16.4, PEG 0.21) but every horizon forecasts down 20–70% — model says top. |
| 18 | SAN | AVOID | 2.5 | Price pinned at 100% of range on 1d/1wk with fc_long −67%; classic top. |
| 19 | FIX | AVOID | 2.3 | Weekly fc_long −85% at 71% of range after 33% run — Kronos calling exhaustion. |
| 20 | DAC | AVOID | 2.2 | RSI 71.3 at 95% of weekly range with fc_long −38% — chase risk despite earnings beat. |
| 21 | BFH | AVOID | 2.1 | At 100% of weekly range with 1d fc_mid −41%; RSI 67 — sell setup. |
| 22 | AGEN | AVOID | 2.0 | RSI 76 and price at 99–100% of 1d/1wk range with fc_short −59%; a blow-off. |
| 23 | S | AVOID | 1.9 | Weekly at 100% of range with all-TF negative forecasts (−7 to −30%). |
| 24 | ZURA | AVOID | 1.8 | All-TF fc_long negative (−4 to −38%) despite William Blair Outperform. |
| 25 | SNDA | AVOID | 1.6 | 1d fc_long −28% and 1wk −33%; no thesis except analyst PT $50. |
| 26 | DRTS | AVOID | 1.5 | 1d fc_long −68% overwhelms positive trial data; wait for stabilization. |
| 27 | TRT | AVOID | 1.4 | PE 308, 1d fc_long −70%, weekly −65% — the AI-GPU order news is priced in. |
| 28 | BFLY | AVOID | 1.3 | 1d fc_long −65% at 98% of range; perfYear +487% — mean reversion setup. |
| 29 | APGE | AVOID | 1.0 | RSI 78.6 at 99.75% of weekly range with 1wk fc_long −69%; AbbVie profit cut hangover. |
| 30 | EXFY | AVOID | 0.9 | Every TF negative, targetUpsidePct −39.5, fundamental_score −5 — broken. |
Get AI top picks & forecasts on any stock
K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord